Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Saylor

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinomaEudora Lee, Ralina Karagenova, Charles Lu, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 16, 2025
Efficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysisZsombor T Gal, Ethan A Wetzel, Brian V Nahed, et al.
Neuro-Oncology Practice|May 11, 2026
Perspectives and challenges of multidisciplinary collaboration in the treatment of metastatic spinal disease: Insights from an international surveyJantijn J G J Amelink, Bram T van Munster, Olivier Q Groot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastasesRichard J Lee, Philip J Saylor, M Dror Michaelson, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Neurosurgery|March 15, 2019
Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal ValidationAditya V Karhade, Quirina C B S Thio, Paul T Ogink, et al.
Neurosurgery|November 27, 2018
Development of Machine Learning Algorithms for Prediction of 30-Day Mortality After Surgery for Spinal MetastasisAditya V Karhade, Quirina C B S Thio, Paul T Ogink, et al.
Nature Communications|September 30, 2022
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinomaAdele M Alchahin, Shenglin Mei, Ioanna Tsea, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
Neurosurgery|June 11, 2020
Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on OutcomesGanesh M Shankar, Laura A Van Beaver, Bryan D Choi, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinomaEudora Lee, Ralina Karagenova, Charles Lu, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 16, 2025
Efficacy of bone-modifying agents in preventing vertebral complications of multiple myeloma: a systematic review and meta-analysisZsombor T Gal, Ethan A Wetzel, Brian V Nahed, et al.
Neuro-Oncology Practice|May 11, 2026
Perspectives and challenges of multidisciplinary collaboration in the treatment of metastatic spinal disease: Insights from an international surveyJantijn J G J Amelink, Bram T van Munster, Olivier Q Groot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastasesRichard J Lee, Philip J Saylor, M Dror Michaelson, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Neurosurgery|March 15, 2019
Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal ValidationAditya V Karhade, Quirina C B S Thio, Paul T Ogink, et al.
Neurosurgery|November 27, 2018
Development of Machine Learning Algorithms for Prediction of 30-Day Mortality After Surgery for Spinal MetastasisAditya V Karhade, Quirina C B S Thio, Paul T Ogink, et al.
Nature Communications|September 30, 2022
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinomaAdele M Alchahin, Shenglin Mei, Ioanna Tsea, et al.
International Journal of Radiation Oncology, Biology, Physics|August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 TrialJohn J Coen, Joseph P Rodgers, Philip J Saylor, et al.
Neurosurgery|June 11, 2020
Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on OutcomesGanesh M Shankar, Laura A Van Beaver, Bryan D Choi, et al.
Pageof 9